Columbia MD 乳腺癌临床试验
15项针对 乳腺癌的研究正在 Columbia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Northwest Hospital Center, Randallstown · 距离 9 英里
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster · 距离 25 英里
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
招募中2 期
- Maryland Oncology Hematology, Laurel · 距离 10 英里
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, Columbia
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
招募中3 期
- Clinical Trial Site, Catonsville · 距离 6 英里
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
招募中3 期
- Maryland Oncology Hematology P.A., Columbia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Maryland Oncology Hematology, P.A., Columbia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Northwest Hospital Center, Randallstown · 距离 9 英里
E-Mindfulness Approaches for Living After Breast Cancer
招募中3 期
- Central Maryland Radiation Oncology in Howard County, Columbia
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Northwest Hospital, Randallstown · 距离 9 英里
- William E. Kahlert Regional Cancer Center, Westminster · 距离 25 英里
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- Maryland Oncology Hematology P.A., Columbia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- Central Maryland Radiation Oncology in Howard County, Columbia
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
招募中2 期
- Maryland Oncology Hematology, Columbia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster · 距离 25 英里
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
招募中
- Central Maryland Oncology Center, Columbia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
招募中观察性研究
- Maryland Oncology Hematology, PA, Columbia
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Columbia的其他研究
- 肺癌7 项研究
- 非小细胞肺癌6 项研究
- 超重6 项研究
- 前列腺癌6 项研究
- 肥胖症5 项研究
- 转移性癌症5 项研究
- 膀胱癌5 项研究
- 结直肠癌5 项研究
- 黑色素瘤4 项研究
- 胰腺癌4 项研究
- 结肠癌4 项研究
- 子宫内膜癌3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。